23 CAR § 146-106
(b) Pharmacy network adequacy.
(1)
(c) Compensation.
(1)
(2)
(i) The commissioner shall not review reimbursement complaints or concerns under this section on a case-by-case basis for a pharmacist or pharmacy.
(b) (b) The extent to which the compensation or reimbursement program has an impact on pharmacist or pharmacy participation in health benefit plans either on a statewide basis or in a significant geographical area of the state.
(B) For purposes of this section, the commissioner may consider a pharmacist's or pharmacy's declination to provide covered prescription drugs under Arkansas Code § 17-92-507(e) as a circumstance negatively impacting participation, because, in this instance, the health benefit plan is unable to provide its covered member with a covered prescription drug through one (1) of its in-network pharmacists or pharmacies.
(C) A healthcare insurer or payor using a PBM for administration of pharmacy benefits shall take the following measures:
(5)
(6) Confidentiality. Any information obtained by the commissioner from a review, investigation, or examination of compensation under this section shall be considered confidential under Arkansas Code § 23-61-103, § 23-61-107(a)(4), and § 23-61-207 and, in addition, shall be considered proprietary, as information that would provide an advantage to a competitor, under the Freedom of Information Act of 1967, Arkansas Code § 25-19-101 et seq., in Arkansas Code § 25-19-105(b)(9).